Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection

Hepato-Gastroenterology

Volumn 54, Issue 75, 2007, Pages 889-891

  Inoue, Tomoko ^a   Fuke, Hiroyuki ^a   Yamamoto, Norihiko ^a   Ito, Keiichi ^a   Yoneda, Kentaro ^a   Yutaka, Yamanaka ^a   Shiraki, Katsuya ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Flare; HBV; Lamivudine

Indexed keywords

BILIRUBIN; LAMIVUDINE;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTIVIRAL AGENTS; BILIRUBIN; HEPATITIS B, CHRONIC; HUMANS; IMMUNOSUPPRESSION; LAMIVUDINE; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 34250155226     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lee WM: Hepatitis B virus infection. N Engl J Med 1997; 337:1733-1745.
2. Lok As, Liang RH, Chiu EK, Wong KL, Chan TK, Tod D: Reactivation of hepatitis B virus replication in patients receiving cytotoxic chemotherapy. Report of a prospective study. Gastroenterology 1991; 100:182-188.
3. Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS, et al: Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective with identification of risk factors. J Med Virol 2000; 62:299-307.
4. Liao CA, Lee CM, Wu HC, Wang MC, Lu SN, Eng HL: Lamivudine therapy for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma. Br J Haematol 2002; 116:166-169.
5. Jang JW, Choi JY, Bae SH, Kim CW, Yoon SK, Cho SH, Yang JM, Ahn BM, Lee CD, Lee YS, Chung KW, Sun HS: Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma. J Hepatol 2004; 41:427-435.
6. Shimizu D, Nomura K, Matsumoto Y, Ueda K, Yamaguchi K, Minami M, Itoh Y, Horiike S, Morita M, Taniwaki M, Okanoue T: Hepatitis B virus reactivation in a patient undergoing steroid-free chemotherapy. World J Gastroenterol 2004; 10:2301-2302.
7. Ozguroglu M, Bilici A, Turna H, Serdengecti S: Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma. Med Oncol 2004; 21:67-72.
8. Berger A, Preiser W, Kachel HG, Sturmer M, Doerr HW: HBV reactivation after kidney transplantation. J Clin Virol 2005; 32:162-165.
9. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray DF: A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998; 339:61-68.
10. Shibolet O, Ilan Y, Gillis S, Hubert A, Shouval D, Safadi R: Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood 2002; 100:391-396.
11. Chan HLY, Tsang SWC, Hui Y, Leung NWY, Chan FKL, Sung JJY: The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis Bwith jaundice. J Viral Hepatol 2002; 9:424-428.
12. Chien RN, Lin CH, Liaw YF: The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B. J Hepatol 2003; 38:322-327.
13. Tsubota A, Arase Y, Suzuki Y, Suzuki F, Sezaki H, Hosaka T, Akuta N, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kumada H: Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 2005; 20:426-432.
14. Kawai Y, Dtegaya S, Hata M, Kawahito M, Imamura S, Yoshida A, Tsutani H, Ueda T: Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature. Ann Hematol 2001; 80:482-484.